Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)
CUSIP: 413197104
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,644,670
- Total 13F shares
- 51,269,247
- Share change
- +808,356
- Total reported value
- $1,620,478,469
- Put/Call ratio
- 22%
- Price per share
- $31.60
- Number of holders
- 276
- Value change
- +$22,306,889
- Number of buys
- 165
- Number of sells
- 98
Quarterly Holders Quick Answers
What is CUSIP 413197104?
CUSIP 413197104 identifies HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 413197104:
Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Valor Management LLC |
13F
|
Company |
11%
|
6,618,033
|
$219,652,515 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
10%
from 13D/G
|
6,511,873
|
$216,129,064 | — | 31 Mar 2025 | |
| Marshman Fund Trust II |
3/4/5
13D/G
|
10%+ Owner |
11%
from 13D/G
|
6,051,120
|
$183,364,064 | — | 01 Nov 2024 | |
| FMR LLC |
13F
|
Company |
9.3%
|
5,342,525
|
$177,318,420 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.2%
|
4,699,353
|
$155,971,526 | — | 31 Mar 2025 | |
| Andreas Wicki |
3/4/5
|
Director |
—
class O/S missing
|
2,147,943
|
$71,655,378 | — | 12 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
1,579,034
|
$52,408,138 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2.2%
|
1,288,787
|
$42,774,841 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.1%
|
1,224,794
|
$40,650,913 | — | 31 Mar 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
2.1%
|
1,194,961
|
$39,661,000 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
965,750
|
$32,060,103 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.5%
|
887,537
|
$29,457,353 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.5%
|
862,406
|
$28,623,255 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
840,371
|
$27,891,913 | — | 31 Mar 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.3%
|
753,547
|
$25,010,225 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
656,104
|
$21,776,111 | — | 31 Mar 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.86%
|
496,959
|
$16,494,069 | — | 31 Mar 2025 | |
| venBio Partners LLC |
13F
|
Company |
0.85%
|
489,194
|
$16,236,349 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.84%
|
484,797
|
$16,090,412 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.81%
|
466,072
|
$15,468,930 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.77%
|
443,687
|
$14,725,972 | — | 31 Mar 2025 | |
| New Vernon Capital Holdings II LLC |
13F
|
Company |
0.85%
|
488,424
|
$14,716,000 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.76%
|
439,884
|
$14,599,750 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
403,542
|
$13,393,560 | — | 31 Mar 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.69%
|
398,411
|
$13,223,261 | — | 31 Mar 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.64%
|
368,665
|
$12,235,991 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.6%
|
345,807
|
$11,477,334 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.6%
|
344,766
|
$11,442,784 | — | 31 Mar 2025 | |
| CAPITAL MANAGEMENT CORP /VA |
13F
|
Company |
0.59%
|
341,961
|
$11,349,686 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.55%
|
319,704
|
$10,610,975 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
309,404
|
$10,269,119 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.52%
|
300,724
|
$9,981,030 | — | 31 Mar 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.52%
|
300,000
|
$9,957,000 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.49%
|
281,200
|
$9,333,028 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.48%
|
277,518
|
$9,210,588 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.47%
|
269,322
|
$8,938,797 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.45%
|
262,238
|
$8,703,692 | — | 31 Mar 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.38%
|
220,704
|
$7,325,166 | — | 31 Mar 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.37%
|
213,838
|
$7,097,000 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.37%
|
213,416
|
$7,083,277 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.37%
|
211,894
|
$7,032,762 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.36%
|
205,340
|
$6,815,235 | — | 31 Mar 2025 | |
| Man Group plc |
13F
|
Company |
0.33%
|
187,367
|
$6,218,711 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.32%
|
182,525
|
$6,058,005 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.32%
|
181,824
|
$6,034,739 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.29%
|
168,000
|
$5,575,920 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
166,340
|
$5,520,818 | — | 31 Mar 2025 | |
| Bridge City Capital, LLC |
13F
|
Company |
0.28%
|
160,739
|
$5,334,927 | — | 31 Mar 2025 | |
| Universal- Beteiligungs- und Servicegesellschaft mbH |
13F
|
Individual |
0.27%
|
153,326
|
$5,088,891 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.26%
|
151,493
|
$5,028,053 | — | 31 Mar 2025 |
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q2 2025
As of 30 Jun 2025,
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by
276 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,269,247 shares.
The largest 10 holders included
BlackRock, Inc., Valor Management LLC, VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, AMERICAN CENTURY COMPANIES INC, LSV ASSET MANAGEMENT, MARSHALL WACE, LLP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
278
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
267
Q2 2025 holders
276
Holder diff
9
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.